Search
for
Sort by
Research 481–510 of 1000+
- Diphencyprone in the treatment of Satoyoshi syndrome
- Sex hormones and related compounds, including hormonal contraceptives
- Baseline methotrexate does not impact the incidence of infliximab infusion reactions: Results from a Canadian real-world treatment registry
- Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen
- Ashy dermatosis: Treatment with clofazimine
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Treatment guidelines in adult women
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Polycystic Ovary Syndrome
- A Guide to Studying Human Hair Follicle Cycling In Vivo
- The role of androgen and androgen receptor in skin-related disorders
- HAIR REGROWTH
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- A review of diagnosis and treatment of acne in adult female patients
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Polycystic Ovarian Syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Finasteride
- Hair Loss in Women
- Safety of testosterone treatment in postmenopausal women
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- The Hair Follicle: A Paradoxical Androgen Target Organ
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Nanotechnology in Dermatology
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders